Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program - Bookhart, BK; Haskell, L; Bamber, L (J Med Econ, 2014)